MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET 2021-2028

Lifesciences | Healthcare & Wellness

MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET 2021-2028

Market by Therapy Type, Type of Disease, Route of Administration, and Country | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton’s research report predicts that the hormone replacement therapy market in the Middle East and Africa is likely to register growth at a compound annual growth rate of 7.43% through the estimated years of 2021-2028.


Report scope can be customized per your requirements. Request For Customization 

The countries considered for analysis in this market are:

•        The United Arab Emirates

•        Turkey

•        South Africa

•        Saudi Arabia

•        Rest of Middle East & Africa

Enhancements in the healthcare infrastructure are estimated to amplify the demand for hormone replacement therapy in the region’s countries, including Saudi Arabia, Qatar, and others. Furthermore, governments are taking initiatives as directed by the WHO or other organizations, which further supports the growth of the hormone replacement therapy market in Middle East and Africa region.

A significant number of Saudi Arabia women are considered to prefer hormone replacement therapy as an ideal method to treat menopausal symptoms. Additionally, the number of women suffering from breast cancer is increasing rapidly and is among the leading causes of death each year. Hormone therapy is known to be used only for breast cancers with receptors for the biologically occurring hormones, estrogen, or progesterone. Hence, as mentioned above, these factors majorly add to the development of the hormone replacement therapy market across Saudi Arabia.

Furthermore, the UAE is among the significant destinations for health tourists seeking quality hormone replacement therapy treatment. Moreover, it is considered to be a hub for enhanced healthcare services, offering hormone replacement therapy at an affordable cost. Along with this, the price of this therapy is relatively less compared to the US and European countries, propelling the hormone replacement therapy market on a positive growth trajectory.

Teva Pharmaceutical Industries Ltd is a pharmaceutical company focusing on developing, manufacturing, and marketing generic, branded, and active pharmaceuticals. Among its popular products is testosterone gel 1.62% CIII, which is used for replacement therapy in adult males to treat conditions related to the absence of endogenous testosterone. It offers its products to various end-users and is headquartered in Israel. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON HORMONE REPLACEMENT THERAPY MARKET

2.2. KEY INSIGHTS

2.2.1. INTRODUCTION OF NEW DRUG DELIVERY SYSTEMS FOR HORMONE REPLACEMENT

2.2.2. MODERN SEDENTARY LIFESTYLES

2.3. PORTER’S FIVE FORCES MODEL

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTE PRODUCTS

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY STRATEGIC DEVELOPMENTS

2.6.1. ACQUISITIONS & MERGERS

2.6.2. PRODUCT LAUNCH & DEVELOPMENTS

2.6.3. CONTRACTS AND PARTNERSHIPS

2.6.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES

2.7. MARKET DRIVERS

2.7.1. RISE IN AWARENESS PERTAINING TO HEALTH PROBLEMS DURING MENOPAUSE

2.7.2. INCREASE IN PREVALENCE OF HORMONAL DISORDERS

2.7.3. NEW PRODUCT LAUNCHES BY MAJOR GIANTS

2.8. MARKET RESTRAINTS

2.8.1. HIGH COST OF TREATMENT

2.8.2. ADVERSE REACTIONS ASSOCIATED WITH HORMONE REPLACEMENT THERAPY

2.9. MARKET OPPORTUNITIES

2.9.1. AVAILABILITY OF ALTERNATIVE THERAPY OFFERS OPPORTUNITIES FOR THE MARKET’S GROWTH

2.9.2. LAUNCH OF TELEMEDICINE CLINICAL PRACTICE SERVICES

3. MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET - BY THERAPY TYPE

3.1. ESTROGEN HORMONE REPLACEMENT THERAPY

3.2. THYROID HORMONE REPLACEMENT THERAPY

3.3. TESTOSTERONE HORMONE REPLACEMENT THERAPY

3.4. HUMAN GROWTH HORMONE REPLACEMENT THERAPY

3.5. PROGESTOGEN HORMONE REPLACEMENT THERAPY

4. MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET - BY TYPE OF DISEASE

4.1. MENOPAUSE

4.2. MALE HYPOGONADISM

4.3. GROWTH HORMONE DEFICIENCY

4.4. HYPOTHYROIDISM

4.5. OTHER TYPE OF DISEASES

5. MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET - BY ROUTE OF ADMINISTRATION

5.1. ORAL

5.2. PARENTERAL

5.3. TRANSDERMAL

5.4. OTHER ROUTES OF ADMINISTRATION

6. MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET – COUNTRY OUTLOOK

6.1.1. SAUDI ARABIA

6.1.2. UNITED ARAB EMIRATES

6.1.3. TURKEY

6.1.4. SOUTH AFRICA

6.1.5. REST OF MIDDLE EAST & AFRICA

7. COMPETITIVE LANDSCAPE

7.1. ABBOTT LABORATORIES

7.2. AMGEN

7.3. ANI PHARMACEUTICALS

7.4. BAYER AG

7.5. DR REDDY’S LABORATORIES LTD

7.6. ELI LILLY & COMPANY

7.7. GENENTECH INC

7.8. IPSEN

7.9. MERCK KGAA

7.10. NOVARTIS AG

7.11. NOVEN PHARMACEUTICALS INC

7.12. NOVO NORDISK A/S

7.13. PFIZER INC

7.14. TEVA PHARMACEUTICAL INDUSTRIES LTD

7.15. VIATRIS INC (MYLAN NV)

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1. OBJECTIVES OF STUDY

8.1.2. SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1. PRIMARY DATA SOURCES

8.2.2. SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1. EVALUATION OF PROPOSED MARKET

8.3.2. IDENTIFICATION OF DATA SOURCES

8.3.3. ASSESSMENT OF MARKET DETERMINANTS

8.3.4. DATA COLLECTION

8.3.5. DATA VALIDATION & ANALYSIS

List of Tables

TABLE 1:       MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2:       VENDOR SCORECARD

TABLE 3:       LIST OF ACQUISITIONS & MERGERS

TABLE 4:       LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 5:       LIST OF CONTRACTS AND PARTNERSHIPS

TABLE 6:       MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 7:       MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)

TABLE 8:       MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)

TABLE 9:       MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 2:     MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2020 & 2028 (IN %)

FIGURE 3:     MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY ESTROGEN HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 4:     MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY THYROID HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 5:     MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY TESTOSTERONE HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 6:     MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY HUMAN GROWTH HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 7:     MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY PROGESTOGEN HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 8:     MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2020 & 2028 (IN %)

FIGURE 9:     MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY MENOPAUSE, 2021-2028 (IN $ MILLION)

FIGURE 10:  MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY MALE HYPOGONADISM, 2021-2028 (IN $ MILLION)

FIGURE 11:  MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY GROWTH HORMONE DEFICIENCY, 2021-2028 (IN $ MILLION)

FIGURE 12:  MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY HYPOTHYROIDISM, 2021-2028 (IN $ MILLION)

FIGURE 13:  MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY OTHER TYPE OF DISEASES, 2021-2028 (IN $ MILLION)

FIGURE 14:  MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2020 & 2028 (IN %)

FIGURE 15:  MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY ORAL, 2021-2028 (IN $ MILLION)

FIGURE 16:  MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY PARENTERAL, 2021-2028 (IN $ MILLION)

FIGURE 17:  MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY TRANSDERMAL, 2021-2028 (IN $ MILLION)

FIGURE 18:  MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY OTHER ROUTES OF ADMINISTRATION, 2021-2028 (IN $ MILLION)

FIGURE 19:  SAUDI ARABIA HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 20:  UNITED ARAB EMIRATES HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 21:  TURKEY HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 22:  SOUTH AFRICA HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 23:  REST OF MIDDLE EAST & AFRICA HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;